TEST CATALOG ORDERING & RESULTS SPECIMEN HANDLING CUSTOMER SERVICE EDUCATION & INSIGHTS
Test Catalog

Test ID: CDGF    
Celiac Disease Gluten-Free Cascade, Serum and Whole Blood

Method Description Describes how the test is performed and provides a method-specific reference

HLA-DQ Typing:

LABType applies Luminex technology to the reverse sequence-specific oligonucleotide probe (SSO) DNA typing method. First, target DNA is PCR-amplified using a group-specific primer. The PCR product is biotinylated, which allows it to be detected using R-Phycoerythrin-conjugated streptavidin. The PCR product is denatured and allowed to rehybridize to complementary DNA probes conjugated to fluorescently coded microspheres. A flow analyzer identifies the fluorescent intensity of phycoerythrin on each microsphere. The HLA Class II allele or allele groups of the sample is determined by the positive and negative bead ID's using a computer software program. The assignment of the HLA typing is based on the reaction pattern compared to patterns associated with published HLA gene sequences.(Package insert: One Lambda, LABType SSO Typing. rev. 30, 12/2018)

 

Immunoglobulin A (IgA):

Total IgA levels are measured by immunonephelometry. Rabbit antisera that specifically recognizes human IgA is added to the patient sample. Immune complexes form between the human IgA and the rabbit immunoglobulins; the immune complexes scatter light that is passed through the sample. The intensity of the scattered light is related to the amount of human IgA in the sample. The concentration of IgA in the sample is calculated from a multipoint calibration curve.(Behring Nephelometer II Operations Instruction Manual. Dade Behring, Inc. Newark, DE 19714. 2008)

 

Tissue Transglutaminase (tTG) Antibody, IgA/IgG:

IgA and IgG antibodies to tTG are detected by enzyme-linked immunosorbent assay (ELISA). Recombinant human tTG antigen expressed in Escherichia coli is adsorbed to wells of a microtiter plate under conditions that preserve the native state of the antigen. Diluted patient sera are added to the microtiter plate wells under conditions that allow binding of the antibodies to the tTG antigen. Unbound sample constituents are washed away and horseradish peroxidase (HRP)-labeled antihuman IgA or IgG antibody conjugate is added to each well. After a second incubation, unbound HRP-label is removed and bound conjugate is detected by adding tetramethylbenzidine (TMB) chromogenic substrate. After a final incubation, colored product is measured spectrophotometrically; the absorbance of the patient sample is compared to the positive calibrator. The absorbance is directly proportional to the level of IgA or IgG antibodies to tTG, which is expressed in arbitrary units.(QUANTA Lite R h-tTG IgA and IgG. Inova Diagnostics, Inc. San Diego, CA, 92131. rev. 7, 1/2015)

 

Gliadin (Deamidated) Antibody, IgA/IgG:

IgA and IgG antibodies to deamidated gliadin peptides are detected by ELISA. Purified peptides are adsorbed to wells of a microtiter plate under conditions that preserve the native state of the antigen. Diluted patient sera are added to the microtiter plate wells under conditions that allow binding of the antibodies to the deamidated gliadin peptides. Unbound sample constituents are washed away and HRP-labeled antihuman IgA or IgG antibody conjugate is added to each well. After a second incubation, unbound HRP-label is removed and bound conjugate is detected by adding TMB chromogenic substrate. After a final incubation, colored product is measured spectrophotometrically; the absorbance of the patient sample is compared to the positive calibrator. The absorbance is directly proportional to the level of IgA or IgG antibodies to deamidated gliadin peptides, which is expressed in arbitrary units.(QUANTA Lite Gliadin IgA II and IgG II. INOVA Diagnostics, Inc. San Diego, CA, 92131. rev. 1, 4/2015)

PDF Report Indicates whether the report includes an additional document with charts, images or other enriched information

No

Day(s) Performed Outlines the days the test is performed. This field reflects the day that the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time before the test is performed. Some tests are listed as continuously performed, which means that assays are performed multiple times during the day.

IgA, tTG IgG, Gliadin IgG, Gliadin IgA, tTG IgA: Monday through Saturday

HLA-DQ Typing: Monday through Friday

Report Available The interval of time (receipt of sample at Mayo Clinic Laboratories to results available) taking into account standard setup days and weekends. The first day is the time that it typically takes for a result to be available. The last day is the time it might take, accounting for any necessary repeated testing.

7 to 14 days

Performing Laboratory Location Indicates the location of the laboratory that performs the test

Rochester